MRK · News · 20260808N
India Litigation Jurisdiction
Merck & Co., Inc. · 2026-08-08 · Importance 21 · Surprise 42 · In source text
The U.S. Court of Appeals for the Third Circuit ruled that a contract dispute involving Merck and a now-defunct Indian pharmaceutical company must be litigated in India. The dispute concerns a terminated business relationship between the parties. The ruling changes the litigation venue but provides no damages amount, settlement value, or expected resolution timeframe.
Key facts
- The U.S. Court of Appeals for the Third Circuit ruled that a legal dispute between Merck and a now-defunct Indian pharmaceutical company must be litigated in India. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | contingent | — | The U.S. Court of Appeals for the Third Circuit ruled that a legal dispute between Merck and a now-defunct Indian pharmaceutical company… |